Summer is the perfect time for grilling, which means there will be a lot of interest in grill deals with the season’s arrival. There’s no shortage of options out there, but here are a couple of ...

Ironwood Pharmaceuticals plans to buy a Swiss biotech for $1 billion as the Boston drug firm seeks to strengthen its focus on treatments for gastrointestinal diseases. Ironwood, which makes the ...

Jefferies initiated coverage of Ironwood Pharmaceuticals (NASDAQ:IRWD) with a buy rating, stating that it believes the Street is underappreciating the potential upside from its GLP-2 agonist drug ...

StockNews.com upgraded shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) from a hold rating to a buy rating in a research report report published on Saturday. IRWD has been the subject of ...

Analyst Jason Butler of JMP Securities reiterated a Buy rating on Ironwood Pharma (IRWD – Research Report), with a price target of $22.00. Jason Butler’s Buy rating for Ironwood Pharma is driven by ...